Income Statement Traphaco

Stocks

TRA

VN000000TRA8

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 2026-08-13			5-day change	1st Jan Change
37,700.00 ^VND	+1.34%		-0.53%	+0.53%

07-31	Traphaco Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-20	Traphaco Joint Stock Company Announces to Pay Second Cash Dividend for the Year 2025, Payable on August 7, 2026	CI

13e9857d3a7833e0d4690a.tcXbqEJUjwkPoMRIiQwY0OgGDKQCCe2FgJAxZGxFiYk.mLDo7gYi40hmkfw_5D9otJtETYkyTtrOtcV8VDsI0LjhspDxJRrpeWT1ow

Published financial data: TRAPHACO

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	2,161B	2,399B	2,299B	2,347B	2,657B
Total Revenues	2,161B	2,399B	2,299B	2,347B	2,657B
Cost of Goods Sold, Total	1,013B	1,056B	1,054B	1,111B	1,233B
Gross Profit	1,147B	1,343B	1,245B	1,236B	1,424B
Selling General & Admin Expenses, Total	821B	993B	912B	930B	1,100B
Other Operating Expenses, Total	821B	993B	912B	930B	1,100B
Operating Income	327B	351B	333B	306B	324B
Interest Expense, Total	-5.43B	-1.09B	-3.94B	-3.88B	-6.96B
Interest And Investment Income	10.38B	17.03B	29.93B	21.74B	25.45B
Net Interest Expenses	4.95B	15.94B	25.99B	17.86B	18.49B
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-88.83M	-105M	146M	883M	514M
Other Non Operating Income (Expenses)	-730M	2.04B	1.16B	-556M	4.63B
EBT, Excl. Unusual Items	331B	368B	361B	325B	348B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
EBT, Incl. Unusual Items	331B	368B	361B	325B	348B
Income Tax Expense	66.24B	74.94B	75.4B	67.28B	69.19B
Earnings From Continuing Operations	264B	294B	285B	257B	278B
Net Income to Company	264B	294B	285B	257B	278B
Minority Interest	-22.88B	-24.37B	-22.02B	-18.34B	-28.71B
Net Income - (IS)	242B	269B	263B	239B	250B
Preferred Dividend and Other Adjustments	27B	33.26B	33.81B	32.19B	32.87B
Net Income to Common Incl Extra Items	215B	236B	229B	207B	217B
Net Income to Common Excl. Extra Items	215B	236B	229B	207B	217B
Per Share Items
Net EPS - Basic	2.59K	2.85K	2.77K	2.49K	2.62K
Basic EPS - Continuing Operations	2.59K	2.85K	2.77K	2.49K	2.62K
Basic Weighted Average Shares Outstanding	82.9M	82.9M	82.9M	82.9M	82.9M
Net EPS - Diluted	2.59K	2.85K	2.77K	2.49K	2.62K
Diluted EPS - Continuing Operations	2.59K	2.85K	2.77K	2.49K	2.62K
Diluted Weighted Average Shares Outstanding	82.9M	82.9M	82.9M	82.9M	82.9M
Normalized Basic EPS	2.22K	2.48K	2.45K	2.23K	2.27K
Normalized Diluted EPS	2.22K	2.48K	2.45K	2.23K	2.27K
Dividend Per Share	1.5K	1.5K	2K	2K	-
Payout Ratio	56.32	82.56	21.48	74.26	66.94
Supplemental Items
EBITDA	409B	434B	424B	394B	412B
EBITA	329B	351B	334B	307B	324B
EBIT	327B	351B	333B	306B	324B
EBITDAR	409B	434B	424B	394B	413B
Total Revenues (As Reported)	2,161B	2,399B	2,299B	2,347B	2,657B
Effective Tax Rate - (Ratio)	20.03	20.34	20.91	20.73	19.91
Current Domestic Taxes	-	-	78.4B	64.93B	79.25B
Total Current Taxes	69.95B	75.03B	78.4B	64.93B	79.25B
Deferred Domestic Taxes	-	-	-3B	2.35B	-10.07B
Total Deferred Taxes	-3.71B	-91.58M	-3B	2.35B	-10.07B
Normalized Net Income	184B	206B	203B	185B	189B
Interest on Long-Term Debt	6.09B	-	-	-	-
Supplemental Operating Expense Items
Advertising Expense	127B	174B	168B	185B	190B
Selling and Marketing Expenses	555B	661B	614B	625B	758B
General and Administrative Expenses	266B	332B	297B	305B	342B
Net Rental Expense, Total	164M	164M	214M	214M	489M
Imputed Operating Lease Interest Expense	135M	42.77M	64.77M	37.07M	167M
Imputed Operating Lease Depreciation	29.36M	122M	149M	177M	322M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	211B	176B	367B	208B	176B
Short Term Investments	287B	316B	405B	512B	520B
Trading Asset Securities, Total	-	10B	10B	10B	10B
Total Cash And Short Term Investments	498B	502B	782B	730B	706B
Accounts Receivable, Total	149B	177B	206B	234B	338B
Other Receivables	3.74B	9.47B	19.97B	9.06B	26.04B
Total Receivables	153B	187B	226B	243B	364B
Inventory	382B	479B	468B	549B	563B
Prepaid Expenses	2.53B	1.22B	2.69B	1.5B	2.34B
Other Current Assets, Total	58.2B	57.7B	51.79B	69.52B	110B
Total Current Assets	1,094B	1,226B	1,530B	1,594B	1,745B
Gross Property Plant And Equipment	1,027B	1,064B	1,148B	1,206B	1,260B
Accumulated Depreciation	-535B	-599B	-685B	-756B	-830B
Net Property Plant And Equipment	493B	465B	463B	450B	431B
Long-term Investments	500M	500M	500M	500M	500M
Goodwill	0	-	-	-	-
Other Intangibles, Total	59.63B	59.63B	58.82B	60B	57.45B
Deferred Tax Assets Long-Term	21.06B	21.15B	24.15B	21.79B	31.86B
Other Long-Term Assets, Total	39.34B	43.62B	47.03B	42.99B	57.05B
Total Assets	1,707B	1,816B	2,124B	2,169B	2,323B
Liabilities
Accounts Payable, Total	123B	186B	144B	181B	257B
Accrued Expenses, Total	141B	138B	138B	108B	165B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	26.86B	40B	168B	190B	133B
Current Income Taxes Payable	17.76B	11.56B	31.2B	19.12B	20.51B
Unearned Revenue Current, Total	38B	47.3B	58.84B	44B	20.93B
Other Current Liabilities	93.01B	12.5B	94.32B	94.74B	36.63B
Total Current Liabilities	440B	436B	635B	636B	633B
Long-Term Debt	-	-	-	-	2.93B
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	440B	436B	635B	636B	636B
Common Stock, Total	415B	415B	415B	415B	415B
Additional Paid In Capital	133B	133B	133B	133B	133B
Retained Earnings	610B	717B	822B	862B	995B
Treasury Stock	-3.59M	-3.59M	-3.59M	-3.59M	-3.59M
Comprehensive Income and Other	10.41B	10.27B	10.14B	10B	9.87B
Total Common Equity	1,168B	1,275B	1,379B	1,419B	1,553B
Minority Interest	99.34B	105B	110B	113B	133B
Total Equity	1,268B	1,381B	1,489B	1,533B	1,686B
Total Liabilities And Equity	1,707B	1,816B	2,124B	2,169B	2,323B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	82.9M	82.9M	82.9M	82.9M	82.9M
ECS Total Common Shares Outstanding	82.9M	82.9M	82.9M	82.9M	82.9M
Book Value / Share	14.09K	15.38K	16.64K	17.12K	18.73K
Tangible Book Value	1,109B	1,215B	1,321B	1,359B	1,495B
Tangible Book Value Per Share	13.37K	14.66K	15.93K	16.4K	18.04K
Total Debt	26.86B	40B	168B	190B	136B
Net Debt	-471B	-462B	-614B	-540B	-569B
Debt Equivalent Oper. Leases	1.31B	1.31B	1.71B	1.71B	3.91B
Minority Interest, Total (Incl. Fin. Div)	99.34B	105B	110B	113B	133B
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	117B	156B	165B	205B	179B
Inventories - Work In Process, Total	55.96B	74.47B	62.25B	64.84B	54.7B
Inventories - Finished Goods, Total	211B	249B	242B	280B	331B
Inventories - Others	318M	528M	355M	314M	298M
Buildings, Total	356B	358B	365B	376B	378B
Machinery, Total	658B	694B	766B	813B	847B
Full Time Employees	-	1.48K	1.48K	1.67K	1.55K
Assets under Capital Lease - Gross	-	-	-	-	5.64B
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-275M
Accumulated Allowance for Doubtful Accounts (Supple)	5.78B	8.78B	10.37B	11.7B	16.02B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	242B	269B	263B	239B	250B
Depreciation & Amortization - CF	79.8B	83.52B	90.65B	87.44B	88.12B
Amortization of Goodwill and Intangible Assets - (CF)	2.51B	164M	164M	164M	164M
Depreciation & Amortization, Total	82.31B	83.68B	90.82B	87.61B	88.29B
Amortization of Deferred Charges, Total - (CF)	2.33B	3.18B	3.68B	3.8B	5.33B
(Gain) Loss From Sale Of Asset	-10.39B	-17.35B	-30.27B	-22.03B	-25.92B
Other Operating Activities, Total	-1.61B	-21.73B	4.08B	-25.75B	-6.14B
Change in Trading Asset Securities	-	-10B	-	-	-
Change In Accounts Receivable	11.26B	-32.38B	-26.13B	-44.97B	-172B
Change In Inventories	-32.53B	-98.34B	9.28B	-80.62B	-14.55B
Change In Accounts Payable	-2.45B	74.66B	-21.64B	-2.36B	165B
Change in Other Net Operating Assets	-242M	-3.2B	-5.09B	5.03B	-6.21B
Cash from Operations	290B	248B	288B	160B	283B
Capital Expenditure	-31.42B	-58.7B	-101B	-86.67B	-109B
Sale of Property, Plant, and Equipment	227M	997M	354M	308M	5.66B
Investment in Marketable and Equity Securities, Total	-178B	-29.21B	-90.69B	-107B	-7.73B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	10.58B	13.52B	22.48B	30.05B	22.9B
Cash from Investing	-198B	-73.39B	-168B	-163B	-88.66B
Short Term Debt Issued, Total	-	60B	-	196B	-
Long-Term Debt Issued, Total	-	-	218B	-	231B
Total Debt Issued	-	60B	218B	196B	231B
Short Term Debt Repaid, Total	-	-46.86B	-	-174B	-
Long-Term Debt Repaid, Total	-54.15B	-	-90B	-	-290B
Total Debt Repaid	-54.15B	-46.86B	-90B	-174B	-290B
Common Dividends Paid	-136B	-222B	-56.54B	-177B	-167B
Common & Preferred Stock Dividends Paid	-136B	-222B	-56.54B	-177B	-167B
Cash from Financing	-190B	-209B	71.42B	-156B	-227B
Foreign Exchange Rate Adjustments	-16.13M	-47.71M	45.34M	108M	-141M
Miscellaneous Cash Flow Adjustments	240M	-	-	-	-
Net Change in Cash	-97.97B	-34.85B	191B	-159B	-32.34B
Supplemental Items
Cash Interest Paid	5.51B	1.04B	3.85B	3.91B	6.93B
Cash Income Tax Paid (Refund)	75.43B	81.03B	58.76B	77.01B	77.86B
Levered Free Cash Flow	262B	101B	248B	57.7B	60.17B
Unlevered Free Cash Flow	266B	101B	250B	60.13B	64.52B
Change In Net Working Capital	-8.21B	146B	-47.87B	136B	122B
Net Debt Issued / Repaid	-54.15B	13.14B	128B	21.94B	-59.39B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	12.16	12.44	10.58	8.92	9.01
Return on Total Capital	16.04	16.14	13.54	11.33	11.42
Return On Equity %	21.68	22.17	19.88	17.03	17.3
Return on Common Equity	19.1	19.31	17.29	14.78	14.59
Margin Analysis
Gross Profit Margin %	53.1	55.99	54.15	52.68	53.59
SG&A Margin	37.99	41.38	39.65	39.62	41.4
EBITDA Margin %	18.92	18.1	18.45	16.79	15.51
EBITA Margin %	15.23	14.62	14.51	13.06	12.2
EBIT Margin %	15.11	14.61	14.5	13.06	12.19
Income From Continuing Operations Margin %	12.24	12.24	12.41	10.96	10.48
Net Income Margin %	11.18	11.22	11.45	10.18	9.4
Net Avail. For Common Margin %	9.93	9.83	9.98	8.81	8.16
Normalized Net Income Margin	8.51	8.58	8.85	7.86	7.09
Levered Free Cash Flow Margin	12.13	4.2	10.77	2.46	2.26
Unlevered Free Cash Flow Margin	12.29	4.23	10.88	2.56	2.43
Asset Turnover
Asset Turnover	1.29	1.36	1.17	1.09	1.18
Fixed Assets Turnover	4.18	5.01	4.96	5.14	6.04
Receivables Turnover (Average Receivables)	14.09	14.7	12	10.67	9.28
Inventory Turnover (Average Inventory)	2.76	2.45	2.23	2.18	2.22
Short Term Liquidity
Current Ratio	2.49	2.81	2.41	2.51	2.76
Quick Ratio	1.48	1.58	1.59	1.53	1.69
Operating Cash Flow to Current Liabilities	0.66	0.57	0.45	0.25	0.45
Days Sales Outstanding (Average Receivables)	25.91	24.83	30.41	34.3	39.32
Days Outstanding Inventory (Average Inventory)	132.23	148.91	163.91	167.59	164.54
Average Days Payable Outstanding	46.86	48.99	57.73	49.87	64.16
Cash Conversion Cycle (Average Days)	111.28	124.76	136.59	152.03	139.7
Long Term Solvency
Total Debt/Equity	2.12	2.9	11.28	12.39	8.07
Total Debt / Total Capital	2.07	2.82	10.14	11.02	7.47
LT Debt/Equity	-	-	-	-	0.17
Long-Term Debt / Total Capital	-	-	-	-	0.16
Total Liabilities / Total Assets	25.75	23.99	29.89	29.33	27.4
EBIT / Interest Expense	60.11	322.25	84.61	78.97	46.53
EBITDA / Interest Expense	75.26	399.17	107.66	101.54	59.21
(EBITDA - Capex) / Interest Expense	69.48	345.22	82.14	79.21	43.48
Total Debt / EBITDA	0.07	0.09	0.4	0.48	0.33
Net Debt / EBITDA	-1.15	-1.06	-1.45	-1.37	-1.38
Total Debt / (EBITDA - Capex)	0.07	0.11	0.52	0.62	0.45
Net Debt / (EBITDA - Capex)	-1.25	-1.23	-1.9	-1.76	-1.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.2	11.02	-4.16	2.09	13.21
Gross Profit, 1 Yr. Growth %	11.25	17.06	-7.32	-0.68	15.16
EBITDA, 1 Yr. Growth %	16.55	6.2	-3.03	-7.9	3.6
EBITA, 1 Yr. Growth %	22.31	6.58	-4.86	-8.03	5.75
EBIT, 1 Yr. Growth %	21.37	7.35	-4.91	-8.07	5.7
Earnings From Cont. Operations, 1 Yr. Growth %	22.02	10.98	-2.81	-9.78	8.16
Net Income, 1 Yr. Growth %	23.39	11.41	-2.19	-9.2	4.45
Normalized Net Income, 1 Yr. Growth %	26.17	12.02	-1.22	-9.26	2.14
Diluted EPS Before Extra, 1 Yr. Growth %	24.33	12.38	-2.45	-9.6	4.98
Accounts Receivable, 1 Yr. Growth %	-5.49	19.03	15.98	13.85	44.4
Inventory, 1 Yr. Growth %	8.71	25.25	-2.32	17.4	2.41
Net Property, Plant and Equip., 1 Yr. Growth %	-9.13	-5.63	-0.42	-2.87	-4.22
Total Assets, 1 Yr. Growth %	3.41	6.39	16.94	2.12	7.09
Tangible Book Value, 1 Yr. Growth %	8.42	9.64	8.64	2.94	10
Common Equity, 1 Yr. Growth %	8.24	9.15	8.17	2.9	9.4
Cash From Operations, 1 Yr. Growth %	-16.18	-14.68	16.28	-44.54	77.17
Capital Expenditures, 1 Yr. Growth %	-28.79	86.81	71.26	-13.79	26.32
Levered Free Cash Flow, 1 Yr. Growth %	-3.66	-61.58	145.93	-76.71	4.27
Unlevered Free Cash Flow, 1 Yr. Growth %	-4.91	-61.81	146.71	-75.97	7.3
Dividend Per Share, 1 Yr. Growth %	0	0	33.33	0	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.4	12.1	3.15	-1.08	7.5
Gross Profit, 2 Yr. CAGR %	10.46	14.12	4.16	-4.06	6.95
EBITDA, 2 Yr. CAGR %	14.86	11.26	1.85	-5.09	-1.85
EBITA, 2 Yr. CAGR %	20.18	14.17	0.67	-6.48	-1.4
EBIT, 2 Yr. CAGR %	19.72	14.15	1.03	-6.5	-1.43
Earnings From Cont. Operations, 2 Yr. CAGR %	24.51	16.37	3.86	-6.36	-1.22
Net Income, 2 Yr. CAGR %	25.48	17.25	4.39	-5.76	-2.62
Normalized Net Income, 2 Yr. CAGR %	25.28	18.88	5.19	-5.33	-3.73
Diluted EPS Before Extra, 2 Yr. CAGR %	26.16	16.9	4.55	-6.22	-2.66
Accounts Receivable, 2 Yr. CAGR %	6.23	6.06	17.49	14.91	28.22
Inventory, 2 Yr. CAGR %	2.47	16.69	10.61	7.09	9.65
Net Property, Plant and Equip., 2 Yr. CAGR %	-7.96	-7.39	-3.06	-1.66	-3.55
Total Assets, 2 Yr. CAGR %	4.22	4.89	11.54	9.28	4.57
Tangible Book Value, 2 Yr. CAGR %	6.69	9.03	9.14	5.75	6.42
Common Equity, 2 Yr. CAGR %	6.42	8.69	8.66	5.51	6.1
Cash From Operations, 2 Yr. CAGR %	15.64	-15.43	-0.4	-19.69	-0.87
Capital Expenditures, 2 Yr. CAGR %	-0.79	15.34	78.87	21.51	4.36
Levered Free Cash Flow, 2 Yr. CAGR %	23.24	-39.16	-2.79	-24.31	-50.72
Unlevered Free Cash Flow, 2 Yr. CAGR %	20.23	-39.74	-2.93	-23	-49.22
Dividend Per Share, 2 Yr. CAGR %	0	0	15.47	15.47	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.31	11.94	6.4	2.8	3.47
Gross Profit, 3 Yr. CAGR %	7.07	12.62	6.47	2.52	1.96
EBITDA, 3 Yr. CAGR %	10.13	11.9	6.53	-1.22	-1.96
EBITA, 3 Yr. CAGR %	13.23	15.47	7.42	-2.33	-2.59
EBIT, 3 Yr. CAGR %	12.94	15.45	7.4	-2.1	-2.6
Earnings From Cont. Operations, 3 Yr. CAGR %	14.81	19.83	9.59	-0.9	-1.75
Net Income, 3 Yr. CAGR %	15.63	20.6	10.37	-0.36	-2.47
Normalized Net Income, 3 Yr. CAGR %	16.37	20.7	11.76	0.13	-2.9
Diluted EPS Before Extra, 3 Yr. CAGR %	15.93	20.5	9.95	-0.49	-2.68
Accounts Receivable, 3 Yr. CAGR %	8.59	10.34	9.27	16.27	24
Inventory, 3 Yr. CAGR %	4.25	9.56	9.97	12.83	5.51
Net Property, Plant and Equip., 3 Yr. CAGR %	-7.35	-7.19	-5.13	-3	-2.52
Total Assets, 3 Yr. CAGR %	2.4	4.94	8.76	8.31	8.54
Tangible Book Value, 3 Yr. CAGR %	4.83	7.67	8.9	7.04	7.15
Common Equity, 3 Yr. CAGR %	4.6	7.32	8.52	6.71	6.79
Cash From Operations, 3 Yr. CAGR %	19.84	4.49	-5.96	-18.06	4.54
Capital Expenditures, 3 Yr. CAGR %	-10.38	22.51	31.58	40.24	23.1
Levered Free Cash Flow, 3 Yr. CAGR %	25.02	-16.43	-3.08	-39.62	-15.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.27	-17.97	-3.6	-39.05	-13.99
Dividend Per Share, 3 Yr. CAGR %	0	0	10.06	10.06	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.58	5.1	5.04	6.53	6.84
Gross Profit, 5 Yr. CAGR %	2.9	5.24	5.9	5.63	6.66
EBITDA, 5 Yr. CAGR %	1.28	3.53	6.74	4.92	3.28
EBITA, 5 Yr. CAGR %	-1.14	1.66	8.03	6.12	3.79
EBIT, 5 Yr. CAGR %	-1.29	1.65	8.02	6.11	3.78
Earnings From Cont. Operations, 5 Yr. CAGR %	2.99	2.42	10.3	8.57	5.13
Net Income, 5 Yr. CAGR %	2.78	2.22	10.99	9.27	4.98
Normalized Net Income, 5 Yr. CAGR %	3.34	2.52	11.76	9.52	5.29
Diluted EPS Before Extra, 5 Yr. CAGR %	2.57	1.67	10.75	8.94	4.66
Accounts Receivable, 5 Yr. CAGR %	1.37	7.01	12.07	12.14	16.49
Inventory, 5 Yr. CAGR %	4.6	7.55	6.75	8.56	9.84
Net Property, Plant and Equip., 5 Yr. CAGR %	0.92	-6.94	-5.66	-5.01	-4.5
Total Assets, 5 Yr. CAGR %	4.38	3.77	5.96	6.66	7.07
Tangible Book Value, 5 Yr. CAGR %	4.8	4.5	6.53	6.9	7.9
Common Equity, 5 Yr. CAGR %	4.69	4.34	6.21	6.59	7.55
Cash From Operations, 5 Yr. CAGR %	9.72	5.99	11.29	-5.95	-3.96
Capital Expenditures, 5 Yr. CAGR %	-34.02	-15.45	18.16	22.11	19.93
Levered Free Cash Flow, 5 Yr. CAGR %	52.14	-8.51	13.05	-19.68	-26.05
Unlevered Free Cash Flow, 5 Yr. CAGR %	52	-8.58	12.03	-20.02	-25.4
Dividend Per Share, 5 Yr. CAGR %	3.71	0	5.92	5.92	-